Zhao J, Xu N, Zhu S, Nie L, Zhang M, Zheng L, et al. Genomic and evolutionary characterization of concurrent intraductal carcinoma and adenocarcinoma of the prostate. Cancer Res. 2024;84:154–67.
Li J, Xu C, Lee HJ, Ren S, Zi X, Zhang Z, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580:93–99.
Article ADS CAS PubMed Google Scholar
Lozano R, Salles DC, Sandhu S, Aragón IM, Thorne H, López-Campos F, et al. Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer. Eur J Cancer. 2021;147:74–83.
Article CAS PubMed Google Scholar
Wang X, Zhou L, Qi L, Zhang Y, Yin H, Gan Y et al. High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate. Prostate Cancer Prostatic Dis. 2023; Online ahead of print.
Russo GI, Soeterik T, Puche-Sanz I, Broggi G, Lo Giudice A, De Nunzio C, et al. Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023;26:646–54.
Smith SC, Gandhi JS, Moch H, Aron M, Compérat E, Paner GP, et al. Similarities and differences in the 2019 ISUP and GUPS recommendations on prostate cancer grading: a guide for practicing pathologists. Adv Anat Pathol. 2021;28:1–7.
Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, et al. Intraductal carcinoma of the prostate: pathogenesis and molecular perspectives. Eur Urol Focus. 2021;7:955–63.
留言 (0)